• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Ziphius

Monday, June 03, 2024
CP
Immunology
Ziphius is a biotechnology company focused on the development of self-amplifying RNA-based (saRNA) vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform to allow for a higher and prolonged protein/antigen expression at lower doses (compared to conventional mRNA) with reduced toxicity. This platform has the potential for a ‘plug and play’ approach offering the possibility of fast development/scale-up and production. These attributes makes it well suited as platform to improve pandemic preparedness.
Ziphius
Company Website: http://www.ziphius.org
Lead Product in Development: Infectious disease vaccine

Website

http://www.ziphius.org

Company HQ City

New York

Company HQ State

New York

Company HQ Country

United States

CEO/Top Company Official

Chris Cardon

Lead Product in Development

Infectious disease vaccine

Development Phase of Primary Product

Pre-Clinical
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS